Cargando…

A study on prevention of bleeding complications using lusutrombopag for safe RFA in patients with hepatocellular carcinoma with low platelet counts: prospective observational study

BACKGROUND: Platelet (PLT) transfusion was the most practical way to increase patients’ PLT counts before invasive hepatic procedures such as radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). A novel drug that raises the PLT count by acting on the thrombopoietin receptor has recently...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Hideo, Ohki, Takamasa, Kanezaki, Mineo, Teratani, Takuma, Sato, Shinpei, Obi, Shuntaro, Sato, Takahisa, Akamatsu, Masatoshi, Uchino, Koji, Taniguchi, Hiroyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364390/ https://www.ncbi.nlm.nih.gov/pubmed/37488476 http://dx.doi.org/10.1186/s12876-023-02879-0

Ejemplares similares

Impact of Adverse Events on the Progression-Free Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study
por: Ohki, Takamasa, et al.
Publicado: (2020)

Immune checkpoint inhibitor in liver cancer—unique regional differences
por: Obi, Shuntaro, et al.
Publicado: (2020)

Bleeding events in lusutrombopag‐treated thrombocytopenic patients
por: Giannini, Edoardo Giovanni, et al.
Publicado: (2021)

Assessing the periprocedural magnitude of platelet count change in response to lusutrombopag
por: Brown, Robert S., et al.
Publicado: (2021)

Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors
por: Shiina, Shuichiro, et al.
Publicado: (2012)

Efficacy of Repeated Lusutrombopag Administration for Thrombocytopenia in a Patient Scheduled for Invasive Hepatocellular Carcinoma Treatment
por: Sato, Shuichi, et al.
Publicado: (2017)

Effects of Lusutrombopag on Post-invasive Procedural Bleeding in Thrombocytopenic Patients with Chronic Liver Disease
por: Yoshida, Manami, et al.
Publicado: (2021)

Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a retrospective study
por: Kawai, Toshihiro, et al.
Publicado: (2016)

A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation
por: Tateishi, Ryosuke, et al.
Publicado: (2018)

Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures
por: Takada, Hitomi, et al.
Publicado: (2019)

Relationship between response to lusutrombopag and splenic volume
por: Uojima, Haruki, et al.
Publicado: (2018)

Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
por: Sakamaki, Akira, et al.
Publicado: (2017)

Alternative Test Systems RFA
Publicado: (1994)

Lusutrombopag for thrombocytopenia in Chinese patients with chronic liver disease undergoing invasive procedures
por: Ding, Zhenbin, et al.
Publicado: (2022)

Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration
por: Yoon, Jeong Hee, et al.
Publicado: (2018)

Laparoscopic RFA with splenectomy for hepatocellular carcinoma
por: Hu, Kunpeng, et al.
Publicado: (2016)

Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MS
por: Wang, Bo, et al.
Publicado: (2020)

Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive Procedures
por: Nishida, Yuno, et al.
Publicado: (2020)

A cost‐effectiveness analysis of lusutrombopag for thrombocytopenia in patients with chronic liver disease in Japan
por: Miki, Norikane, et al.
Publicado: (2021)

The sonographer’s role in RFA therapy of liver lesions
por: Mandarano, S, et al.
Publicado: (2009)

The Bundesminister for Science and Technology (RFA) visits CERN
por: CERN PhotoLab
Publicado: (1979)

Hemothorax an Unusual Complication during Liver RFA
por: Tsagouli, Paraskevi, et al.
Publicado: (2011)

A New Perspective for Predicting the Therapeutic Success of RFA in Solid BTNs: Quantitative Initial RFA Ratio by Contrast-Enhanced Ultrasound
por: Zhu, Yaqiong, et al.
Publicado: (2022)

Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters
por: Katsube, Takayuki, et al.
Publicado: (2020)

Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L‐PLUS 2)
por: Peck‐Radosavljevic, Markus, et al.
Publicado: (2019)

Efficacy and safety of repeated use of lusutrombopag prior to radiofrequency ablation in patients with recurrent hepatocellular carcinoma and thrombocytopenia
por: Ishikawa, Toru, et al.
Publicado: (2019)

Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study
por: Nomoto, Hiroaki, et al.
Publicado: (2020)

A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series
por: Biolato, Marco, et al.
Publicado: (2022)

Usefulness of intraductal RFA in patients with malignant biliary obstruction
por: Han, Sung Yong, et al.
Publicado: (2020)

RFA and benign thyroid nodules: Review of the current literature
por: Muhammad, Haris, et al.
Publicado: (2021)

The effect of rfaD and rfaF of Haemophilus parasuis on lipooligosaccharide induced inflammation by NF-κB/MAPKs signaling in porcine alveolar macrophages
por: ZENG, Ze, et al.
Publicado: (2018)

Allosteric control of the RNA polymerase by the elongation factor RfaH
por: Svetlov, Vladimir, et al.
Publicado: (2007)

Fast Estimation of the Vascular Cooling in RFA Based on Numerical Simulation
por: Kröger, T., et al.
Publicado: (2010)

Functional regions of the N-terminal domain of the antiterminator RfaH
por: Belogurov, Georgiy A, et al.
Publicado: (2010)

Rfa2 is specifically dephosphorylated by Pph3 in Candida albicans
por: Wang, Haitao, et al.
Publicado: (2013)

Ablative Therapy for Esophageal Dysplasia and Early Malignancy: Focus on RFA
por: Tuttle, Rebecca, et al.
Publicado: (2014)

Interdomain contacts control folding of transcription factor RfaH
por: Tomar, Sushil Kumar, et al.
Publicado: (2013)

Origins and Molecular Evolution of the NusG Paralog RfaH
por: Wang, Bing, et al.
Publicado: (2020)

Efficacy of percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma in elderly patients
por: Benevento, R, et al.
Publicado: (2011)

Characterization of the Interaction between Rfa1 and Rad24 in Saccharomyces cerevisiae
por: Piya, Gunjan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uq3o219osim19i0d9g4sf1ri1a